Mark Lappe
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$319K
Total bought / sold$3.6M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 28SEC | INBXInhibrx Biosciences, Inc. | Buy | 3,324733,872 held (+0%) | $98.87 | $329K | -3.9% |
| Sep 28SEC | INBXInhibrx Biosciences, Inc. | Buy | 2,176736,048 held (+0%) | $99.60 | $217K | -4.6% |
| Sep 28SEC | INBXInhibrx Biosciences, Inc. | Buy | 1,500737,548 held (+0%) | $98.88 | $148K | -3.9% |
| Sep 28SEC | INBXInhibrx Biosciences, Inc. | Buy | 3,000740,548 held (+0%) | $101.70 | $305K | -6.6% |
| Sep 8SEC | INBXInhibrx Biosciences, Inc. | Buy | 5,895711,443 held (+1%) | $99.29 | $585K | -4.3% |
| Sep 8SEC | INBXInhibrx Biosciences, Inc. | Buy | 6,605718,048 held (+1%) | $100.64 | $665K | -5.6% |
| Sep 8SEC | INBXInhibrx Biosciences, Inc. | Buy | 1,100719,148 held (+0%) | $107.12 | $118K | -11.3% |
| Sep 8SEC | INBXInhibrx Biosciences, Inc. | Buy | 500719,648 held (+0%) | $108.24 | $54K | -12.2% |
| Sep 8SEC | INBXInhibrx Biosciences, Inc. | Buy | 1,219720,867 held (+0%) | $111.88 | $136K | -15.1% |
| Sep 8SEC | INBXInhibrx Biosciences, Inc. | Buy | 9,681730,548 held (+1%) | $112.28 | $1.1M | -15.4% |
- Buy
CEO Mark Lappe bought $585K of INBX at $99.29 — first open-market purchase in our records.
- Buy
CEO Mark Lappe bought $665K of INBX at $100.64 — largest purchase by this insider in our records.
- Buy
CEO Mark Lappe bought $1.1M of INBX at $112.28 — largest purchase by this insider in our records.